🔎 Trials Near Me

Utama › Tumor Otak › Missouri

Kajian klinikal Tumor Otak di Missouri

13 kajian untuk Tumor Otak sedang mencari peserta di lokasi di Missouri.

Bandar di Missouri

Teks kajian rasmi (Bahasa Inggeris)

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Washington University School of Medicine Siteman Cancer Center, St Louis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Washington University, St Louis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT05786924

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • dan 19 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04511013

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • Saint Luke's Cancer Institute, Kansas City
  • Washington University School of Medicine, St Louis
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06253871

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

  • Washington University School of Medicine, St Louis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07428616

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

  • Siteman Cancer Center at Washington University, St Louis
Mengambil pesertaFasa 1
36 Months – 22 Years · Semua jantina · Dikemas kini 4 Sep 2026 · NCT03911388

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

  • Washington University School of Medicine/Saint Louis Children's Hospital, St Louis
Mengambil pesertaKajian pemerhatian
Umur 8 hingga 21 · Semua jantina · Dikemas kini 17 Jul 2026 · NCT06185686

REMASTer: REcurrent Brain Metastases After SRS Trial

  • WashU, St Louis
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Jun 2026 · NCT05124912

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jun 2026 · NCT03550391

Window of Opportunity Study of DSP-0390 in Gliomas

  • Washington University School of Medicine, St Louis
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06636162

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

  • Washington University School of Medicine, St Louis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Apr 2026 · NCT07462507

7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)

  • University of Missouri, Columbia
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Dis 2025 · NCT07175077

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
  • Saint Francis Medical Center, Cape Girardeau
  • Capital Region Southwest Campus, Jefferson City
  • dan 10 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Okt 2025 · NCT03418961

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.